Cencora Debt to Equity Ratio 2012-2025 | COR
Current and historical debt to equity ratio values for Cencora (COR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cencora debt/equity for the three months ending December 31, 2025 was 3.62.
| Cencora Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $76.27B | $2.10B | 36.39 |
| 2025-09-30 | $74.84B | $1.75B | 42.84 |
| 2025-06-30 | $71.75B | $2.21B | 32.47 |
| 2025-03-31 | $70.01B | $1.18B | 59.34 |
| 2024-12-31 | $68.69B | $0.36B | 189.81 |
| 2024-09-30 | $66.32B | $0.79B | 84.29 |
| 2024-06-30 | $65.71B | $1.06B | 61.96 |
| 2024-03-31 | $62.64B | $1.23B | 51.05 |
| 2023-12-31 | $63.63B | $1.06B | 59.96 |
| 2023-09-30 | $61.89B | $0.67B | 92.89 |
| 2023-06-30 | $60.26B | $0.92B | 65.35 |
| 2023-03-31 | $58.26B | $0.51B | 113.97 |
| 2022-12-31 | $57.83B | $0.07B | 786.22 |
| 2022-09-30 | $56.49B | $0.07B | 792.58 |
| 2022-06-30 | $56.66B | $0.52B | 109.40 |
| 2022-03-31 | $56.40B | $0.91B | 62.25 |
| 2021-12-31 | $56.98B | $0.60B | 94.78 |
| 2021-09-30 | $56.75B | $0.58B | 97.11 |
| 2021-06-30 | $55.52B | $0.41B | 135.94 |
| 2021-03-31 | $47.11B | $-0.10B | -458.31 |
| 2020-12-31 | $46.36B | $-0.51B | -90.62 |
| 2020-09-30 | $45.11B | $-0.84B | -53.73 |
| 2020-06-30 | $36.82B | $3.97B | 9.28 |
| 2020-03-31 | $38.34B | $3.71B | 10.35 |
| 2019-12-31 | $36.95B | $3.07B | 12.04 |
| 2019-09-30 | $36.18B | $2.99B | 12.09 |
| 2019-06-30 | $35.37B | $3.11B | 11.38 |
| 2019-03-31 | $35.77B | $3.04B | 11.77 |
| 2018-12-31 | $36.10B | $3.17B | 11.41 |
| 2018-09-30 | $34.62B | $3.05B | 11.35 |
| 2018-06-30 | $35.03B | $3.28B | 10.69 |
| 2018-03-31 | $35.03B | $3.36B | 10.42 |
| 2017-12-31 | $33.49B | $2.88B | 11.65 |
| 2017-09-30 | $33.25B | $2.06B | 16.11 |
| 2017-06-30 | $32.10B | $2.55B | 12.57 |
| 2017-03-31 | $31.87B | $2.53B | 12.60 |
| 2016-12-31 | $31.80B | $2.12B | 15.03 |
| 2016-09-30 | $31.51B | $2.13B | 14.80 |
| 2016-06-30 | $30.04B | $1.88B | 15.98 |
| 2016-03-31 | $30.30B | $2.19B | 13.83 |
| 2015-12-31 | $29.46B | $1.30B | 22.66 |
| 2015-09-30 | $27.35B | $0.62B | 44.37 |
| 2015-06-30 | $25.76B | $1.58B | 16.35 |
| 2015-03-31 | $25.09B | $1.92B | 13.09 |
| 2014-12-31 | $23.14B | $1.77B | 13.08 |
| 2014-09-30 | $19.58B | $1.96B | 10.00 |
| 2014-06-30 | $18.64B | $1.99B | 9.39 |
| 2014-03-31 | $18.22B | $2.15B | 8.49 |
| 2013-12-31 | $17.55B | $2.25B | 7.81 |
| 2013-09-30 | $16.60B | $2.32B | 7.16 |
| 2013-06-30 | $14.16B | $2.42B | 5.86 |
| 2013-03-31 | $13.77B | $2.35B | 5.87 |
| 2012-12-31 | $13.16B | $2.34B | 5.63 |
| 2012-09-30 | $12.99B | $2.46B | 5.29 |
| 2012-06-30 | $12.82B | $2.93B | 4.38 |
| 2012-03-31 | $12.70B | $2.95B | 4.31 |
| 2011-12-31 | $13.07B | $2.91B | 4.50 |
| 2011-09-30 | $12.12B | $2.87B | 4.23 |
| 2011-06-30 | $11.65B | $3.20B | 3.64 |
| 2011-03-31 | $11.55B | $3.13B | 3.69 |
| 2010-12-31 | $11.17B | $2.96B | 3.77 |
| 2010-09-30 | $11.48B | $2.95B | 3.89 |
| 2010-06-30 | $11.07B | $2.93B | 3.78 |
| 2010-03-31 | $10.99B | $2.83B | 3.88 |
| 2009-12-31 | $10.82B | $2.74B | 3.95 |
| 2009-09-30 | $10.86B | $2.72B | 4.00 |
| 2009-06-30 | $9.95B | $2.78B | 3.57 |
| 2009-03-31 | $9.79B | $2.76B | 3.55 |
| 2008-12-31 | $9.85B | $2.72B | 3.63 |
| 2008-09-30 | $9.51B | $2.71B | 3.51 |
| 2008-06-30 | $9.26B | $2.72B | 3.40 |
| 2008-03-31 | $9.63B | $2.95B | 3.27 |
| 2007-12-31 | $9.73B | $2.89B | 3.37 |
| 2007-09-30 | $9.21B | $3.10B | 2.97 |
| 2007-06-30 | $9.16B | $3.74B | 2.45 |
| 2007-03-31 | $9.49B | $4.10B | 2.32 |
| 2006-12-31 | $9.10B | $3.94B | 2.31 |
| 2006-09-30 | $8.64B | $4.14B | 2.09 |
| 2006-06-30 | $8.64B | $4.23B | 2.04 |
| 2006-03-31 | $8.32B | $4.47B | 1.86 |
| 2005-12-31 | $8.26B | $4.32B | 1.91 |
| 2005-09-30 | $7.10B | $4.28B | 1.66 |
| 2005-06-30 | $7.22B | $4.18B | 1.73 |
| 2005-03-31 | $7.47B | $4.16B | 1.80 |
| 2004-12-31 | $7.10B | $4.21B | 1.69 |
| 2004-09-30 | $7.32B | $4.34B | 1.69 |
| 2004-06-30 | $7.85B | $4.39B | 1.79 |
| 2004-03-31 | $8.16B | $4.26B | 1.92 |
| 2003-12-31 | $7.69B | $4.12B | 1.87 |
| 2003-09-30 | $8.04B | $4.01B | 2.01 |
| 2003-06-30 | $8.72B | $3.89B | 2.24 |
| 2003-03-31 | $8.63B | $3.69B | 2.34 |
| 2002-12-31 | $8.54B | $3.42B | 2.50 |
| 2002-09-30 | $7.90B | $3.32B | 2.38 |
| 2002-06-30 | $7.24B | $3.19B | 2.27 |
| 2002-03-31 | $7.55B | $3.05B | 2.48 |
| 2001-12-31 | $8.02B | $2.92B | 2.75 |
| 2001-09-30 | $7.45B | $2.84B | 2.63 |
| 2001-06-30 | $2.49B | $0.40B | 6.17 |
| 2001-03-31 | $2.42B | $0.37B | 6.62 |
| 2000-12-31 | $2.63B | $0.32B | 8.16 |
| 2000-09-30 | $2.18B | $0.28B | 7.71 |
| 2000-06-30 | $2.16B | $0.25B | 8.80 |
| 2000-03-31 | $1.89B | $0.21B | 8.83 |
| 1999-12-31 | $2.16B | $0.19B | 11.39 |
| 1999-09-30 | $1.89B | $0.17B | 11.39 |
| 1999-06-30 | $1.77B | $0.15B | 12.19 |
| 1999-03-31 | $1.60B | $0.12B | 12.88 |
| 1998-12-31 | $1.71B | $0.10B | 17.41 |
| 1998-09-30 | $1.48B | $0.08B | 19.61 |
| 1998-06-30 | $1.51B | $0.07B | 21.91 |
| 1998-03-31 | $1.58B | $0.05B | 32.98 |
| 1997-12-31 | $1.75B | $0.03B | 59.22 |
| 1997-09-30 | $1.73B | $0.01B | 120.94 |
| 1997-06-30 | $1.51B | $-0.01B | -249.53 |
| 1997-03-31 | $1.53B | $-0.01B | -117.16 |
| 1996-12-31 | $1.38B | $-0.03B | -55.24 |
| 1996-09-30 | $1.23B | $-0.04B | -33.28 |
| 1996-06-30 | $1.15B | $-0.05B | -21.07 |
| 1996-03-31 | $1.19B | $-0.11B | -10.81 |
| 1995-12-31 | $1.14B | $-0.12B | -9.19 |
| 1995-09-30 | $0.97B | $-0.14B | -7.18 |
| 1995-06-30 | $0.99B | $-0.15B | -6.72 |
| 1995-03-31 | $1.15B | $-0.31B | -3.74 |
| 1994-12-31 | $1.03B | $-0.31B | -3.28 |
| 1994-09-30 | $0.88B | $-0.17B | -5.12 |
| 1994-06-30 | $0.00B | 0.00 | |
| 1994-03-31 | $0.00B | 0.00 | |
| 1993-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $62.409B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |